Prime medicine to present at td cowen 45th annual health care conference

Cambridge, mass. , feb. 24, 2025 (globe newswire) -- prime medicine, inc. (nasdaq: prme), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that keith gottesdiener, m.d.
PRME Ratings Summary
PRME Quant Ranking